Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-14 · accession 0001415889-24-016994 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-14 | 2024-06-14 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | S - Sale+OE | $25.00 | -10.6K | 0 | -100% | -$265.0K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | M - OptEx | $14.59 | +10.6K | 10.6K | New | +$154.7K |
| D | 2024-06-14 | 2024-06-14 | JBIO | Verwijs Marinus | Chief TECHNICAL Off | M - OptEx | $0.00 | -10.6K | 68.8K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | S | D | 10,600 | $25.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-14 | M | A | 10,600 | $14.59 | 10,600 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-06-14 | M | D | 10,600 | $0.00 | 68,800 | D | $14.59 · — to 2032-03-20 | 10,600 Common Stock | (F2) 25% of this option vested and became exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter. |